News

Feb 20, 2025

Pharmaceutical Intermediates Market Size to Worth USD 57.15 Bn by 2034 - BioSpace

The increasing prevalence of chronic diseases in the populationand the demand for efficient chemical compounds used in the production of drugsare driving the growth of the market. The Complete Study

The increasing prevalence of chronic diseases in the populationand the demand for efficient chemical compounds used in the production of drugsare driving the growth of the market.

The Complete Study isImmediately Accessible | Download the Sample Pagesof this Report@ https://www.precedenceresearch.com/sample/1356

Pharmaceutical Intermediates Market Key Takeaways

• North America dominated the market with the largestmarket share of 33.14% in 2024.

• The bulk drug intermediates segment held the major marketshare in 2024.

• The analgesicssegment accounted for a largest market share in 2024.

• The CROs/CMOs segment led the global market in 2024.

Market Overview and Industry Potential

A pharmaceutical intermediate is simply the synthesizedchemical compound that is used in the making or productionof active pharmaceutical ingredients (APIs). It is derived during thedifferent stages of the synthesis of APIs. The pharmaceutical intermediateplays an important role in API synthesis, which helps in controlling themodification of chemical structure, purity, and potency. The intermediate isefficiently used in the exact modification of APIs and contributes to theformulation of drugs and other pharmaceutical products.

The increasing pharmaceutical and biopharmaceuticalindustry is accelerating the increased quality of active pharmaceuticalingredients, which drives the demand for pharmaceutical intermediates. Theincreased prevalence of research and development activities in thepharmaceutical and cosmeticsindustry is accelerating the growth of the pharmaceutical intermediates market.

Artificial Intelligence (AI) in Pharmaceutical Processes

The integrationof artificial intelligence in the pharmaceutical industry and productionapplications enhances the overall efficiency in operation and ongoingperformance. AI can address the associated challenges in the pharmaceuticalindustry, such as supply chain management, production, and others. ArtificialIntelligence can help with different pharmaceutical applications suchas rapid control over production quantity and quality, raw materialorchestration, data accuracy, demand forecasting, inventory status, shipmentand delivery, and digital twin.

🔹InDecember 2024, ACG Inspection launched Life Sciences Cloud, a revolutionarycomplete end-to-end analytical and traceability solution vision to developmanufacturing efficiency, deliver production quality, and transformationalsupply chain traceability for enhancing the pharmaceutical industry.

Set up a meeting at your convenienceto get more insights instantly! https://www.precedenceresearch.com/schedule-meeting

Major Trends in the Pharmaceutical Intermediates Market

Rising Demand for the Biopharmaceutical Industry

The increasing prevalence of chronic diseases in thepopulation and the rise in lifestyle diseases such as cardiovascular disease,diabetes, high blood pressure, and other diseases are accelerating the demandfor efficient drugs.

Growing Cosmetic Application

The intermediate is widely used in the formulations ofcosmetics products. The increasing demand for tailored cosmetics products basedon customer needs and skin type boosts the growth of the market.

Government Participation

The increasing government participation in pharmaceuticaland biopharmaceutical applications boosts the demand for pharmaceuticalintermediates. The governments of economically developed countries are highlyinvesting in the expansion and ongoing research and development activities inthe pharmaceutical industry for the innovation and expansion of drug productionto accelerate the growth of the market.

Discover Research Insight@ https://www.precedenceresearch.com/pharmaceutical-intermediates-market

Pharmaceutical Intermediates Market ReportCoverage

Report Coverage

Key Statistics

Market Size in 2025

USD 37.04 Billion

Market Size by 2034

USD 57.15 Billion

CAGR from 2025 to 2034

4.94%

Leading Regio

North America

Fastest Growing Region

Asia Pacific

Base Year

2024

Forecast Period

2025 to 2034

Segments Covered

Product, Application, and Regions

Regions Covered

North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

For questions or customization requests, please reach outto us @ [email protected]| +1 804 441 9344

U.S. Pharmaceutical Intermediates MarketSize to Hit USD 14.16 Bn by 2034

According to Precedence Research. the U.S. pharmaceuticalintermediates market size is calculated at USD 8.71 billion in 2025 and isprojected to surpass around USD 14.16 billion by 2034, growing at a CAGR of5.55% from 2025 to 2034.

North America dominated the pharmaceutical intermediatesmarket in 2024.

The growth of the market is attributed to the availabilityof the developed healthcare and pharmaceutical infrastructure, which causes thedemand for pharmaceutical intermediates for drug formulation. The increasinginvestment in further innovations in chemicals and technology utilization toincrease production and enhance the quality of drugs is accelerating the growthof the market. The increasing research and development activities in thepharmaceutical and cosmetics industry for product innovations and formulationaccelerate the growth of the regional market.

🔹Accordingto the Pharmaceutical Research and Manufacturers of America (PhRMA), inthe United States, the pharmaceutical industry spends 21% of its global revenueon research and development activities in 2023.

🔹PhRMAtrade group members generated global revenues of approximately USD 448billion in 2023, of which 70% is covered by the domestic revenue. Its membersspent USD 96 billion on R&D expenditure globally in 2023, in which thedomestic market accounted for 74% of the worldwide figure.

Asia Pacific is expected to have the fastest growth inthe market during the forecast period.

The growth of the market is attributed to the risingregional population, and the increasing prevalence of chronic diseases inpeople is driving the demand for pharmaceutical intermediates for drugformulation and production. The increasing investment in research anddevelopment activities in innovations and the expansion of drugs are alsoimportant. Additionally, the increasing cosmetics industry and related startupsacross the world are contributing to the market across the region.

🔹Thepharmaceutical industry in India will reach USD 65 billion by 2024 USD 130 billion by 2030 and USD450 billion by 2047.

🔹Indiais the 3rd largest contributor or producer of API, accounting for an 8%share of the Global API Industry. There are 500+ different APIsproduced in India, and 57% of APIs to the prequalified list of the WHO.

Pharmaceutical Intermediates Market Segmentation Analysis:

Product Analysis

The bulk drug intermediates segment dominated the marketwith the largest share in 2024.

Bulk drug c are the type of intermediates that are used asraw material in the formulation or production of bulk drugs. The bulk drugintermediates are highly used by the cosmetics or pharmaceutical industry,mostly in operations like research and development.

The increasing prevalence of chronic diseases in the worldcauses a higher demand for drugs and pharmaceutical products that boosts theresearch and development program for new initiatives toward drug formulation,which drives the demand for bulk drug intermediates. The bulk drug intermediatesare divided into two types: API intermediates and advanced intermediates. Therising demand for pharmaceutical and cosmetics products drives the demand forthe intermediates segment.

The custom intermediates segment is anticipated togrow rapidly over the forecast period.

Custom intermediates are intermediates that arespecifically made according to personalization or the client's demand. It isthe process in which the compound is produced as per the exact needs or specifications.The custom intermediates are basically made for some research program orother commercial applications. The custom intermediates provide enhancedprecision, flexibility, and cost-effectiveness.

Application Analysis

The analgesics segment accounted for the largest pharmaceuticalintermediates market share in 2024.

There is an increasing demand for analgesic drugs for thetreatment of drug therapeutics in different types of diseases to elevate painand provide rapid relief. The increasing population and the rising cases of chronicdiseases such as cancer, arthritis, cardiovascular disease, and others, and therise in the geriatric population that are more likely to get affected bychronic illnesses and lifestyle diseases like high blood pressure, diabetes,and others are collectively driving the demand for the analgesic drugformulation which causes the higher demand for the pharmaceutical intermediatedfor the drug production.

🔹InSeptember 2024, Mankind Pharma, a leading pharmaceutical firm inIndia, announced its entrance into the topical analgesic market via itsconsumer business division.

The anti-cancer drugs segment is expected to show thefastest growth during the forecast period.

The increasing prevalence of cancer around the worldpopulation due to changing lifestyles, environmental impacts, genetics, andothers boosts the demand for efficient treatment and drugs, which boosts thedemand for pharmaceutical intermediates for anti-cancer drug production.

In August 2024, Lupin, a leadingpharmaceutical company, launched a generic cancer treatment drug in the U.S.market. The company launched the Doxorubicin Hydrochloride LiposomeInjection single-dose vials in the U.S.

End User Analysis

The CROs/CMOs segment dominated the pharmaceuticalintermediates market with the largest share in 2024.

The increasing number of CROs/CMOs around the world is dueto the increasing preference for outsourcing drug production. Contractmanufacturing organizations and contractresearch organizations play an important part in the drug productionprocess. The increasing demand to produce different types of drugs viacontract manufacturing organizations and contract researchorganizations is driving the demand for the pharmaceutical intermediatesmarket.

The research laboratories segment is expected to show thefastest growth during the forecast period.

The increasing number of research laboratories ineconomically developed or developing countries that have robust healthcare andpharmaceutical infrastructure boosts the demand for pharmaceuticalintermediates. The pharmaceutical intermediates help in processing thedifferent types of research and development programs that boost the demand forthe pharmaceutical intermediates in the research laboratories.

Browse More Insights:

• Pharmaceutical CRO Market: https://www.precedenceresearch.com/pharmaceutical-cro-market

• Generic Drugs Market: https://www.precedenceresearch.com/generic-drugs-market

• Cancer/Oncology Drugs Market: https://www.precedenceresearch.com/cancer-drugs-market

• Pharmaceutical Contract Manufacturing Market: https://www.precedenceresearch.com/pharmaceutical-contract-manufacturing-market

• Anti-Inflammatory Biologics Market: https://www.precedenceresearch.com/anti-inflammatory-biologics-market

• Contract Development and Manufacturing OrganizationOutsourcing Market: https://www.precedenceresearch.com/contract-development-and-manufacturing-organization-outsourcing-market

• Preclinical CRO Market: https://www.precedenceresearch.com/preclinical-cro-market

• Biopharmaceutical CMO and CRO Market: https://www.precedenceresearch.com/biopharmaceutical-cmo-and-cro-market

• Dermatology CRO Market: https://www.precedenceresearch.com/dermatology-cro-market

• In Vivo CRO Market: https://www.precedenceresearch.com/in-vivo-cro-market

Pharmaceutical Intermediates Market Companies

• Aceto Corporation

• BASF SE

• Chiracon GmbH

• Yin-sheng Bio-tech Co. Ltd.

• Dishman Group

• Green Vision Life Sciences

• Midas Pharma GmbH

• Sanofi SAIS

• Vertellus Holdings LLC.

• Lonza Group

What is Going Around the Globe?

• In July 2024, Pfizer launched the PfizerCentreOne (Booth 1235), an integrated contract manufacturing organization on API synthesis and sterileinjectables fill-finish. The launched brand united Hospira One 2 One, a globalspecialty API provider and sterile injectables CMO.

• In February 2025, Glenmark Pharmaceuticals Inc.,the United States-based pharmaceutical company, launched the LatanoprostOphthalmic Solution. It is the therapeutic andbioequivalent equivalent to the reference listed Xalatan OphthalmicSolution of Upjohn US 2 LLC.

Segments Covered in the Report

By Product

• Chemical Intermediates

• Bulk Drug Intermediates

• Custom Intermediates

By Application

• Analgesics

• Ant-inflammatory Drug

• Cardiovascular Drugs

• Anti-Diabetic Drugs

• Anti-Cancer Drugs

• Others

By End User

• Biotech and Pharma Companies

• Research Laboratory

• CMO/CRO

By Regions

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa (MEA)

Thanks for reading you can alsoget individual chapter-wise sections or region-wise report versions such asNorth America, Europe, or Asia Pacific.

Immediate Delivery Available |Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1356

You can place an order or ask any questions, pleasefeel free to contact at [email protected]| +1 804 441 9344

Precedence Research offers exclusive subscription servicesdesigned to provide in-depth data and analytics insights. With a subscription,you gain access to a comprehensive suite of statistical resources, marketintelligence, and research tools tailored to your business needs. Whetheryou're looking for industry trends, competitive analysis, or future marketprojections, our subscription plans ensure you stay ahead with reliable, up-to-dateinformation.

Browse Our Subscription Plans@ https://www.precedenceresearch.com/get-a-subscription

About Us

Precedence Research is a worldwide market research andconsulting organization. We give an unmatched nature of offering to ourcustomers present all around the globe across industry verticals. PrecedenceResearch has expertise in giving deep-dive market insight along with marketintelligence to our customers spread crosswise over various undertakings. Weare obliged to serve our different client base present over the enterprises ofmedicinal services, healthcare, innovation, next-gen technologies,semi-conductors, chemicals, automotive, and aerospace & defense, among differentventures present globally.

Web: https://www.precedenceresearch.com

Our Blogs:

Towards Healthcare | Towards Packaging | Statifacts | Towards EV Solutions | Towards Dental | Towards Automotive | Nova One Advisor

For Latest Update Follow Us:

LinkedIn| Facebook| Twitter